Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?

OBJECTIVE: To compare the market dynamics of biosimilar infliximab among four Organization for Economic Cooperation and Development (OECD) countries (UK, France, Japan, and Korea) where supply-side and demand-side policies varied greatly, given high and growing expenditure on biological medicines to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yujeong, Kwon, Hye-Young, Godman, Brian, Moorkens, Evelien, Simoens, Steven, Bae, SeungJin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363801/
https://www.ncbi.nlm.nih.gov/pubmed/32733238
http://dx.doi.org/10.3389/fphar.2020.00970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363801/
https://www.ncbi.nlm.nih.gov/pubmed/32733238
http://dx.doi.org/10.3389/fphar.2020.00970

Ejemplares similares